Untitled - travolekar.ru

More documents

Recommendations

Info

452 the earlier finding of a lack of effect of FB on the heart of the anesthetized SD rat,may be explained by the fact that DDA is either absent or else present in FB in such small amounts as to have no significant effect on the heart rate. VII. EFFECTS OF DA AND DDA ON ENDOTHELIAL CELL PRODUCTION OF NITRIC OXIDE As our earlier studies suggested that the relaxation of the isolated rat aorta caused by DA and DDA may be mediated through the L-arginine-NO synthase pathway and NO activation of guanylate cyclase,it was decided to study the effects of DDA on NO production by human endothelial cell cultures. NO was quantified spectrometrically by the accumulation of nitrite produced by endothelial cells cultured in F12 medium for up to 48 hr. This method has been documented by previous workers (22,23). We found that DA and DDA significantly stimulated NO production by endothelial cells in a concentration-dependent manner. This suggests another possible mechanism for their hypotensive effect. FIGURE 9 Comparison of DA, DDA, and FB by TLC. Tan and Zhang
A. paniculata and Cardiovascular System 453 VIII. THIN-LAYER CHROMATOGRAPHIC (TLC) ANALYSIS OF FB FOR THE PRESENCE OF DA AND DDA As our studies thus far suggested that DA and DDA were compounds that, like FB,had significant effects on the cardiovascular parameters of experimental rats,the FB fraction was analyzed by TLC to confirm the presence of these bioactive compounds. No detectable amounts of either DA or DDA were,however,found in FB (Fig. 9). This provided the explanation for a lack of effect of FB on heart rate (unlike DDA) and suggested that the bioactivity in FB could be attributed to compounds other than DA and DDA and that furthermore there were other compound(s) in the crude water extract of A. paniculata that could produce a hypotensive effect. IX. CONCLUSION This series of studies have shown that DA and DDA,having pharmacological actions that lead to a lowering in blood pressure,could serve as potential lead molecules for the development of new antihypertensive compounds. Further purification of FB could yield new compound(s) with hypotensive properties. Last but not least,our studies indicate that the practice of drinking an infusion of leaves of this bitter herb for treating hypertension may indeed have some scientific merit. ACKNOWLEDGMENTS The authors acknowledge the generosity of Professor Masanori Kuroyanagi,School of Pharmaceutical Sciences,University of Shizuoka,52-1 Yada, Shizuoka-shi 422,Japan in supplying andrographolide,DA,and DDA for our studies. We also thank the National University of Singapore for providing the research grant (RP960329) for the study and the research scholarship awarded to C.-Y. Zhang. REFERENCES 1. Cava MP,Chan WR,Stein RP,Willis CR. Andrographolide,further transformations and stereochemical evidence: the structure of andrographolide. Tetrahedron 1965; 21:2617–2632. 2. Balmain A,Connolly JD. Minor diterpenoid constituents of Andrographis paniculata Nees. J Chem Soc Perk Trans 1973; 1:1247–1251. 3. Chan WR,Taylor DR,Willis CR,Bodden RL. The structure on stereochemistry of neoandrographolide,a diterpene glucoside from Andrographis paniculata. Tetrahedron 1971; 27:5081–5091. 4. Chen WM,Liang XT. Deoxyandrographolide-19-D-glucoside from the leaves of Andrographis paniculata. Planta Med 1987; 53:245–246.
Page 2 and 3:
Herbal and Traditional Medicine Mol
Page 4:
Related Volumes Vitamin E in Health
Page 8 and 9:
Although great care has been taken
Page 10 and 11:
iv Series Introduction Normal metab
Page 12 and 13:
vi Series Introduction also highlig
Page 14 and 15:
viii Preface National Center for Co
Page 16 and 17:
x 5. Effects of Phytochemicals in C
Page 18 and 19:
xii 32. Phytochemistry, Pharmacolog
Page 20 and 21:
xiv Contributors Iris F. F. Benzie,
Page 22 and 23:
xvi Contributors Rene´ e J. Grayer
Page 24 and 25:
xviii Contributors Hiroshi Nishida,
Page 26 and 27:
xx Contributors Sissi Wachtel-Galor
Page 28 and 29:
2 Bodeker In this chapter, an attem
Page 30 and 31:
4 Bodeker IV. A POLICY FRAMEWORK Wi
Page 32 and 33:
6 Bodeker medicines with an establi
Page 34 and 35:
8 Bodeker 3. Disputes over patents
Page 36 and 37:
10 Bodeker medical insurers now rou
Page 38 and 39:
12 Bodeker High profitability of tr
Page 40 and 41:
14 Bodeker icum, may be better tole
Page 42 and 43:
16 Bodeker mentary Health Systems a
Page 44 and 45:
18 Bodeker The duration of the toxi
Page 46 and 47:
20 Postmarket regulatory activity c
Page 48 and 49:
22 Provision of information/trainin
Page 50 and 51:
24 Bodeker In view of these trends,
Page 52 and 53:
26 Bodeker vestigate such issues as
Page 54 and 55:
28 Bodeker 4. RCTSs are a powerful
Page 56 and 57:
30 Bodeker Chaudhury R, Bodeker G.
Page 59 and 60:
2 Can Traditional Medicine Coexist
Page 61 and 62:
Can Traditional and Modern Medicine
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
3 Clinical Trials for Herbal Extrac
Page 81 and 82:
Clinical Trials for Herbal Extracts
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
4 Herbal Medicine Criteria for Use
Page 101 and 102:
Criteria for Use of Herbal Medicine
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
5 Effects of Phytochemicals in Chin
Page 115 and 116:
Phytochemicals in CFI and Gut Healt
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141:
Page 144 and 145:
118 Weisburger C. Heterocyclic Arom
Page 146 and 147:
120 about 25-35 min, an intermediat
Page 148 and 149:
TABLE 3 Effect of Tea-Derived Polyp
Page 150 and 151:
124 TABLE 5 MNU-induced Colon Tumor
Page 152 and 153:
126 TABLE 7 UDP-GT Activity in Live
Page 154 and 155:
TABLE 9 Effect of PO Administration
Page 156 and 157:
130 utilized the tritiated chemical
Page 158 and 159:
132 and calcium metabolism and effe
Page 160 and 161:
134 modify host enzyme systems serv
Page 162 and 163:
136 Weisburger 21. Vinson JA. Black
Page 164 and 165:
138 Weisburger 52. Orner GA, Dashwo
Page 166 and 167:
140 Weisburger through mitotic sign
Page 168 and 169:
142 Weisburger multiple-dose admini
Page 170 and 171:
144 Weisburger 140. Valcic S, Timme
Page 172 and 173:
146 Christen FIGURE 1 Number of pub
Page 174 and 175:
148 Christen of the leaves. This sp
Page 176 and 177:
150 TABLE 1 Main Effects of Ginkgo
Page 178 and 179:
152 TABLE 1 Continued Clinical tria
Page 180 and 181:
154 Christen experimental data have
Page 182 and 183:
156 Christen cifically against them
Page 184 and 185:
158 Christen recovery workers: anti
Page 186 and 187:
160 Christen Mazziotta JC, Small GW
Page 188 and 189:
162 Christen 68. Paasche G, Huster
Page 190 and 191:
164 Christen Ginkgo biloba (EGb 761
Page 192 and 193:
166 establish the safety and effica
Page 194 and 195:
168 Bode and Dong activity in vivo
Page 196 and 197:
170 Bode and Dong showed that ginge
Page 198 and 199:
172 inhibited platelet aggregation
Page 200 and 201:
174 Bode and Dong 26. Ahmed RS, Set
Page 202 and 203:
176 Bode and Dong 58. Jewell D, You
Page 205 and 206:
9 Lingzhi Polyphorous Fungus (Ganod
Page 207 and 208:
Lingzhi Polyphorous Fungus (Ganoder
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
10 Epimedium Species Sook Peng Yap
Page 257 and 258:
Epimedium Species 231 A. Genetic Ch
Page 259 and 260:
Epimedium Species 233 IV. SCIENTIFI
Page 261 and 262:
Epimedium Species 235 — The immun
Page 263 and 264:
Epimedium Species 237 osteoporosis.
Page 265 and 266:
Epimedium Species 239 — E. leptor
Page 267 and 268:
Epimedium Species 241 H. Cardiovasc
Page 269 and 270:
Epimedium Species 243 treat yin/yan
Page 271 and 272:
Epimedium Species 245 31. Liao HJ,
Page 273 and 274:
11 Ligusticum chuanxiong Hort. Lis
Page 275 and 276:
Ligusticum chuanxiong Hort. 249 sub
Page 277 and 278:
Ligusticum chuanxiong Hort. 251 3.
Page 279 and 280:
Ligusticum chuanxiong Hort. 253 fec
Page 281 and 282:
Ligusticum chuanxiong Hort. 255 tre
Page 283 and 284:
Page 285:
Page 288 and 289:
262 Liu and Ong FIGURE 1 (a) Plant
Page 290 and 291:
264 FIGURE 2 Continued. Liu and Ong
Page 292 and 293:
266 Liu and Ong fibrosis (23). The
Page 294 and 295:
268 Liu and Ong generally support t
Page 296 and 297:
270 Liu and Ong produced in astrocy
Page 298 and 299:
272 Liu and Ong tricular contractio
Page 300 and 301:
274 Liu and Ong (104), mouse perito
Page 302 and 303:
276 Liu and Ong In accordance with
Page 304 and 305:
278 Liu and Ong bleomycim, doxorubi
Page 306 and 307:
280 Liu and Ong 5. Wu WL, Chang WL,
Page 308 and 309:
282 Liu and Ong mitochondria injury
Page 310 and 311:
284 Liu and Ong 72. Emson PC. Vasoa
Page 312 and 313:
286 Liu and Ong 103. Freeman MW. Ma
Page 314 and 315:
288 Liu and Ong 132. Boyd MR. Bioch
Page 316 and 317:
290 Ko and Mak FIGURE 1 Chemical st
Page 318 and 319:
292 Ko and Mak 1 mmol/kg, respectiv
Page 320 and 321:
294 Ko and Mak cant elevations of d
Page 322 and 323:
296 Ko and Mak FS extract (63). Dur
Page 324 and 325:
298 Ko and Mak tert-butyl hydropero
Page 326 and 327:
300 Ko and Mak GSH to other tissues
Page 328 and 329:
302 Ko and Mak IV. PHARMACOKINETICS
Page 330 and 331:
304 Ko and Mak energizing cellular
Page 332 and 333:
306 Ko and Mak 17. Hikino H, Kiso Y
Page 334 and 335:
308 Ko and Mak thesis. Hong Kong Un
Page 336 and 337:
310 Ko and Mak damage to plasma mem
Page 338 and 339:
312 Ko and Mak 103. Casini AF, Mael
Page 340 and 341:
314 Ko and Mak Rim H. The effect of
Page 342 and 343:
316 Sivakami therapeutic properties
Page 344 and 345:
318 Sivakami one-S-transferase with
Page 346 and 347:
320 Sivakami matory cell infiltrati
Page 348 and 349:
322 Sivakami and selenomethionine w
Page 350 and 351:
324 Sivakami of rats during pregnan
Page 352 and 353:
326 Sivakami 45. Romay C, Ledon N,
Page 354 and 355:
328 FIGURE 1 Averrhoa bilimbi leave
Page 356 and 357:
330 Pushparaj et al. FIGURE 3 The m
Page 358 and 359:
332 Pushparaj et al. the residual f
Page 360 and 361:
334 Pushparaj et al. synthetase inh
Page 362 and 363:
336 medical field. Many have been s
Page 364 and 365:
338 Yap and Ng little effectiveness
Page 366 and 367:
340 TABLE 1 Antitumor Properties of
Page 368 and 369:
342 Yap and Ng FIGURE 2 Electron mi
Page 370 and 371:
344 Yap and Ng after feedingwith le
Page 372 and 373:
346 FIGURE 3 Continued. Yap and Ng
Page 374 and 375:
348 Yap and Ng FIGURE 4 The efficac
Page 376 and 377:
350 Yap and Ng Lentinan has been us
Page 378 and 379:
352 Yap and Ng means for serial tra
Page 380 and 381:
354 study may be to determine the p
Page 382 and 383:
356 Yap and Ng M, ed. Carbohydrates
Page 384 and 385:
358 Yap and Ng 57. Hamuro J, Takats
Page 386 and 387:
360 Yap and Ng oral PSK or LEM admi
Page 388 and 389:
362 Yap and Ng 115. Dieleman-van Za
Page 391 and 392:
17 Cruciferous Vegetables and Chemo
Page 393 and 394:
Cruciferous Vegetables and Chemopre
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428: Cruciferous Vegetables and Chemopre
Page 429 and 430: Cruciferous Vegetables and Chemopre
Page 431: Cruciferous Vegetables and Chemopre
Page 434 and 435: 408 Shi et al. chrysanthemum produc
Page 436 and 437: 410 Shi et al. and antioxidant acti
Page 438 and 439: 412 Shi et al. tory effects against
Page 440 and 441: 414 Shi et al. 1. Antioxidant Activ
Page 442 and 443: 416 Shi et al. fibrosarcoma induced
Page 444 and 445: 418 Shi et al. Both apigenin and lu
Page 446 and 447: 420 Shi et al. in cellular protein
Page 448 and 449: 422 Shi et al. waf1 and p27/kip1. T
Page 450 and 451: 424 Shi et al. FIGURE 5 Apoptosis-i
Page 452 and 453: 426 Shi et al. (77). Pretreatment o
Page 454 and 455: 428 Shi et al. average intake to a
Page 456 and 457: 430 effects, including antioxidant,
Page 458 and 459: 432 Shi et al. 26. Banskota AH, Tez
Page 460 and 461: 434 Shi et al. 58. Han DH, Tachiban
Page 462 and 463: 436 Shi et al. 87. Yin F, Giuliano
Page 464 and 465: 438 Shi et al. 116. Kimata M, Shich
Page 467 and 468: 19 Andrographis paniculata and the
Page 469 and 470: A. paniculata and Cardiovascular Sy
Page 477: A. paniculata and Cardiovascular Sy
Page 481: A. paniculata and Cardiovascular Sy
Page 484 and 485: 458 Offord is almost without odor a
Page 486 and 487: 460 Offord The high antioxidant cap
Page 488 and 489: 462 Offord effectively induce QR in
Page 490 and 491: 464 Offord iron was chelated by the
Page 492 and 493: 466 Offord 14. Houlihan CM, Ho C-T,
Page 494 and 495: 468 Offord 44. Hayes JD, Pulford DJ
Page 497 and 498: 21 Crataegus (Hawthorn) Walter K. K
Page 499 and 500: Crataegus (Hawthorn) 473 TABLE 2 Se
Page 501 and 502: Crataegus (Hawthorn) 475 CoA) reduc
Page 503 and 504: Crataegus (Hawthorn) 477 method was
Page 505 and 506: Crataegus (Hawthorn) 479 FIGURE 4 E
Page 507 and 508: Crataegus (Hawthorn) 481 IV. CARDIO
Page 509 and 510: Crataegus (Hawthorn) 483 shows that
Page 511 and 512: Crataegus (Hawthorn) 485 4. Rigelsk
Page 513: Crataegus (Hawthorn) 487 Differenti
Page 516 and 517: 490 Pervaiz isolated from the roots
Page 518 and 519: 492 grape juices. Initial attempts
Page 520 and 521: 494 Pervaiz (OH ). Excessive accumu
Page 522 and 523: 496 effects on human cardiovascular
Page 524 and 525: 498 Pervaiz Koop, 1999). Preincubat
Page 526 and 527: 500 Pervaiz this regard, an attract
Page 528 and 529:
502 Pervaiz substances, including c
Page 530 and 531:
504 Pervaiz production, depending o
Page 532 and 533:
506 Pervaiz data (K. Ahmad and S. P
Page 534 and 535:
508 Pervaiz mediated gene expressio
Page 536 and 537:
510 Pervaiz Goldberg DM, Hahn SE, P
Page 538 and 539:
512 Pervaiz Kimura Y, Okuda H, Kubo
Page 540 and 541:
514 Pervaiz Pozo-Guisado E, Alvarez
Page 543 and 544:
23 Pharmacological and Physiologica
Page 545 and 546:
Effects of Ginseng 519 FIGURE 1 Str
Page 547 and 548:
Effects of Ginseng 521 amino-termin
Page 549 and 550:
Effects of Ginseng 523 as an antica
Page 551 and 552:
Effects of Ginseng 525 suggest that
Page 553 and 554:
Effects of Ginseng 527 suggest that
Page 555 and 556:
Effects of Ginseng 529 studied in c
Page 557 and 558:
Effects of Ginseng 531 ican ginseng
Page 559 and 560:
Effects of Ginseng 533 rootlet for
Page 561 and 562:
Effects of Ginseng 535 65. Duda RB,
Page 563 and 564:
24 Antioxidant Activities of Prickl
Page 565 and 566:
Prickly Pear Fruit and Its Betalain
Page 567 and 568:
Page 569 and 570:
Page 571 and 572:
Page 573 and 574:
Page 575 and 576:
Page 577 and 578:
Page 579 and 580:
Page 581 and 582:
Page 583 and 584:
25 Antioxidant Activity and Antigen
Page 585 and 586:
Antioxidant Activity of Cassia tora
Page 587 and 588:
Page 589 and 590:
Page 591 and 592:
Page 593 and 594:
Page 595 and 596:
Page 597 and 598:
Page 599 and 600:
26 Sho-saiko-to Ichiro Shimizu Toku
Page 601 and 602:
Sho-saiko-to 575 TABLE 1 Main Activ
Page 603 and 604:
Sho-saiko-to 577 of much of the col
Page 605 and 606:
Sho-saiko-to 579 FIGURE 3 Sho-saiko
Page 607 and 608:
Sho-saiko-to 581 blast-like cells.
Page 609 and 610:
Sho-saiko-to 583 FIGURE 4 Compariso
Page 611 and 612:
Sho-saiko-to 585 In a prospective,
Page 613 and 614:
Sho-saiko-to 587 hepatitis B virus
Page 615 and 616:
Sho-saiko-to 589 medicine (Sho-saik
Page 617 and 618:
Sho-saiko-to 591 59. Rockey DC, Hou
Page 619:
Sho-saiko-to 593 H. Effects of Sho-
Page 622 and 623:
596 Aviram et al. nalized into the
Page 624 and 625:
598 Aviram et al. of the cells resp
Page 626 and 627:
600 Aviram et al. tory, antiallergi
Page 628 and 629:
602 FIGURE 2 The antioxidative effe
Page 630 and 631:
604 Aviram et al. moderate reductio
Page 632 and 633:
606 Aviram et al. tibility of their
Page 634 and 635:
608 interest is the inverse relatio
Page 636 and 637:
610 Aviram et al. 23. Aviram M, Mao
Page 638 and 639:
612 Aviram et al. 55. Aviram M, Ros
Page 640 and 641:
614 Aviram et al. 84. Fuhrman B, Bu
Page 642 and 643:
616 Vaya et al. pausal symptoms inc
Page 644 and 645:
618 Vaya et al. Shiau et al. (23) i
Page 646 and 647:
620 TABLE 2 Histomorphometric Analy
Page 648 and 649:
622 The similarity of the glabridin
Page 650 and 651:
624 Vaya et al. FIGURE 4 The effect
Page 652 and 653:
626 Vaya et al. hydroxyl 4V may pla
Page 654 and 655:
628 Vaya et al. absorbing the ultra
Page 656 and 657:
630 compounds, this knowledge will
Page 658 and 659:
632 Vaya et al. 29. Lee HP, Gourley
Page 660 and 661:
634 Vaya et al. 61. Chang AS, Chang
Page 662 and 663:
636 small molecules and also antiox
Page 664 and 665:
638 FIGURE 1 Relative antioxidant a
Page 666 and 667:
640 Konishi et al. cerebral oxidati
Page 668 and 669:
642 Konishi et al. 3. Halliwell B.
Page 670 and 671:
644 herbal-based products average a
Page 672 and 673:
646 Ang At present, researchers at
Page 674 and 675:
648 Ang eros horn and reindeer antl
Page 676 and 677:
650 Ang experienced male rodents, p
Page 678 and 679:
652 Ang 15. Perry LM, ed. Medicinal
Page 680 and 681:
654 Ang 52. Okano M, Fukamiya N, Le
Page 682 and 683:
656 Ang 93. Ang HH, Chan KL, Gan EK
Page 684 and 685:
658 Li and Tsim FIGURE 1 Cordyceps
Page 686 and 687:
660 Li and Tsim FIGURE 2 (A) The di
Page 688 and 689:
662 Li and Tsim through food that i
Page 690 and 691:
664 Li and Tsim campesterol, and di
Page 692 and 693:
666 Li and Tsim The immune system i
Page 694 and 695:
668 or normal conditioned medium fr
Page 696 and 697:
670 carbon-tetrachloride-induced li
Page 698 and 699:
672 IX. EFFECTS OF CORDYCEPS ON THE
Page 700 and 701:
674 TABLE 3 The Amounts of Major Ch
Page 702 and 703:
676 TABLE 4 Pharmacological Activit
Page 704 and 705:
678 for qualitycontrol of Cordyceps
Page 706 and 707:
680 Li and Tsim 23. Bok JW, Lermer
Page 708 and 709:
682 Li and Tsim extracted from Cord
Page 711 and 712:
32 Phytochemistry, Pharmacology, an
Page 713 and 714:
Brandisia hancei 687 were character
Page 715 and 716:
Brandisia hancei 689 In addition, a
Page 717 and 718:
Brandisia hancei 691 the growth of
Page 719 and 720:
Brandisia hancei 693 D. Hepatoprote
Page 721 and 722:
Brandisia hancei 695 mesangial cell
Page 723 and 724:
Brandisia hancei 697 Acteoside and
Page 725 and 726:
Brandisia hancei 699 8. Li YM, Han
Page 727 and 728:
Brandisia hancei 701 42. Xiong Q, H
Page 729 and 730:
33 Ephedra Christine A. Haller Univ
Page 731 and 732:
Ephedra 705 attached to the amine t
Page 733 and 734:
Ephedra 707 cellular membranes in t
Page 735 and 736:
Ephedra 709 center of the hypothala
Page 737 and 738:
Ephedra 711 mechanism may cause or
Page 739 and 740:
Ephedra 713 the significance of the
Page 741 and 742:
Ephedra 715 free access to alternat
Page 743 and 744:
Ephedra 717 31. Boozer CN, Daly PA,
Page 745:
Ephedra 719 67. Gillies H, Derman W
Page 748 and 749:
722 Mitscher and Cooper fractions.
Page 750 and 751:
724 Mitscher and Cooper products re
Page 752 and 753:
726 Mitscher and Cooper There is ev
Page 754 and 755:
728 FORMULA CHART NO. 2 Cichoric ac
Page 756 and 757:
730 Mitscher and Cooper FORMULA CHA
Page 758 and 759:
732 FORMULA CHART NO. 7 Additional
Page 760 and 761:
734 Mitscher and Cooper deca-8Z,13Z
Page 762 and 763:
736 FORMULA CHART NO. 9 Echinacea p
Page 764 and 765:
738 FORMULA CHART NO. 11 Echinacea
Page 766 and 767:
740 Mitscher and Cooper After 18 hr
Page 768 and 769:
742 Mitscher and Cooper two extempo
Page 770 and 771:
744 Mitscher and Cooper were noted
Page 772 and 773:
746 Mitscher and Cooper no statisti
Page 774 and 775:
748 Mitscher and Cooper VII. TOXICI
Page 776 and 777:
750 6. Are the active constituents
Page 778 and 779:
752 Mitscher and Cooper 33. Johnson
Page 780 and 781:
754 Mitscher and Cooper 94. Beusche
Page 782 and 783:
756 Mitscher and Cooper 157. Dorsch
Page 784 and 785:
758 Klemow et al. H. perforatum has
Page 786 and 787:
760 Klemow et al. 2.0 cm wide. The
Page 788 and 789:
762 Klemow et al. FIGURE 2 Structur
Page 790 and 791:
764 Klemow et al. transmitters like
Page 792 and 793:
766 Klemow et al. perforatum extrac
Page 794 and 795:
768 Klemow et al. depression (60,61
Page 796 and 797:
770 Klemow et al. toxic effects, of
Page 798 and 799:
772 Klemow et al. referred to those
Page 800 and 801:
774 Klemow et al. can result in bre
Page 802 and 803:
776 Klemow et al. 15. Barnes J, And
Page 804 and 805:
778 Klemow et al. 52. Kim HL, Strel
Page 806 and 807:
780 Klemow et al. cell growth by hy
Page 808 and 809:
782 II. ANTICANCER PROPERTIES OF CU
Page 810 and 811:
784 G. Curcumin Downregulates Cyclo
Page 812 and 813:
786 III. EFFECT OF CURCUMIN ON ATHE
Page 814 and 815:
788 Aggarwal et al. fraction had lo
Page 816 and 817:
790 Aggarwal et al. cium ionophore
Page 818 and 819:
792 Aggarwal et al. which may have
Page 820 and 821:
794 VI. CURCUMIN ENHANCES WOUND HEA
Page 822 and 823:
796 Aggarwal et al. the WGA-bound f
Page 824 and 825:
798 Aggarwal et al. derivative exhi
Page 826 and 827:
800 Aggarwal et al. days. At variou
Page 828 and 829:
802 Aggarwal et al. cholesterol. Cu
Page 830 and 831:
804 Aggarwal et al. 9. Limtrakul P,
Page 832 and 833:
806 Aggarwal et al. sis: role of nu
Page 834 and 835:
808 Aggarwal et al. 69. Adelaide J,
Page 836 and 837:
810 Aggarwal et al. 100. Srinivasan
Page 839 and 840:
37 Extracts from the Leaves of Chro
Page 841 and 842:
Chromolaena odorata Extract 815 II.
Page 843 and 844:
Chromolaena odorata Extract 817 E.
Page 845 and 846:
Chromolaena odorata Extract 819 FIG
Page 847 and 848:
Page 849 and 850:
Chromolaena odorata Extract 823
Page 851 and 852:
Page 853 and 854:
Chromolaena odorata Extract 827 and
Page 855 and 856:
Page 857 and 858:
Chromolaena odorata Extract 831 p-H
Page 859 and 860:
Chromolaena odorata Extract 833 the
Page 861 and 862:
Chromolaena odorata Extract 835 Cha
Page 863 and 864:
38 Medicinal Properties of Eucommia
Page 865 and 866:
Medicinal Properties of Eucommia 83
Page 867 and 868:
Page 869 and 870:
Page 871:
Page 874 and 875:
848 popular forms of all complement
Page 876 and 877:
850 IV. GINKGO (GINKGO BILOBA) Erns
Page 878 and 879:
852 Ernst such cases had been repor
Page 880 and 881:
854 ing overall result. There is no
Page 883 and 884:
40 Use of Silicon-Based Oligonucleo
Page 885 and 886:
Si-Based Chip to Authenticate TCM 8
Page 887 and 888:
Page 889 and 890:
Page 891 and 892:
Page 893 and 894:
Page 895 and 896:
Page 897:
Page 900 and 901:
874 Halliwell selected plant extrac
Page 902 and 903:
876 organ damage can also occur. In
Page 904 and 905:
878 arsenic, cadmium, and selenium
Page 906 and 907:
880 Halliwell 6. Ames BW, Gold LS.
Page 909 and 910:
42 Review of Adverse Effects of Chi
Page 911 and 912:
Adverse Effects of CHM 885 When a c
Page 913 and 914:
Adverse Effects of CHM 887 D. Chans
Page 915 and 916:
Adverse Effects of CHM 889 A. Aconi
Page 917 and 918:
Adverse Effects of CHM 891 VI. HERB
Page 919 and 920:
Adverse Effects of CHM 893 A molecu
Page 921 and 922:
Adverse Effects of CHM 895 2C19, 3A
Page 923 and 924:
Adverse Effects of CHM 897 23. Vogl
Page 925 and 926:
Adverse Effects of CHM 899 Brown MB
Page 927:
Adverse Effects of CHM 901 miltiorr
Page 930 and 931:
904 [Adverse effects] schisandrin B
Page 932 and 933:
906 Antiplatlet effects, 253, 529-5
Page 934 and 935:
908 [Cardiovascular system effects]
Page 936 and 937:
910 Cherry, George W., 813-836 Ches
Page 938 and 939:
912 [Cruciferous vegetables (Brassi
Page 940 and 941:
914 [Echinacea (Echinacea augustifo
Page 942 and 943:
916 [Future perspectives] SMS (Shen
Page 944 and 945:
918 Heavy metal contamination, 889-
Page 946 and 947:
920 Illustrations, herbs. See also
Page 948 and 949:
922 Lentinus edodes, 355-363. See a
Page 950 and 951:
924 [Ma huang (Ephedra species)] re
Page 952 and 953:
926 [Overviews] Chromolaena odorata
Page 954 and 955:
928 [Prickly pear (Opuntia ficus in
Page 956 and 957:
930 Regulatory and policy issues, 8
Page 958 and 959:
932 [Scrophulariaceae (Brand hancei
Page 960 and 961:
934 Systematic reviews, 847-855. Se
Page 962 and 963:
936 [Therapeutic uses] antidiabetic
Page 964 and 965:
938 [Therapeutic uses] mycovirus pr
Page 966 and 967:
940 Traditional Chinese medicine. S
show all

Untitled - travolekar.ru

Create successful ePaper yourself

Delete template?

Save as template?